MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Plan-les-ouates
State: Geneve
Zip:
Country: Switzerland
MPC Therapeutics is a biotechnology company. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2023 | Seed Round | 1 | $1.6M |
Plutus Investment Group Plutus Investment Group |
4/2019 | Convertible Note | 1 | $220.1k |
Eclosion SA Eclosion SA |
11/2020 | Grant | $180k | 6/2019 | Grant | 1 | $10.1k |
KICK Ventures KICK Ventures |
7/2019 | Grant | 1 | $658.3k |
InnoSuisse InnoSuisse |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|